DSwiss Inc (DQWS) stock
Close on Oct 19, 2026Market cap $17.38MP/E –Yield –
DSwiss Inc saw revenue fall 53.8% to $1.89M over the twelve months to Jun 30, 2026. Free cash flow was -$287.17K. At the latest close the market valued the company at $17.38M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $17.38M
- P/E ratio
- –
- Price to sales
- 9.21
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1.65%
Fundamentals
- Revenue
- $1.89M
- Net income
- -$245.94K
- EPS, diluted
- -$0.00
- Free cash flow
- -$287.17K
- Book value per share
- -$0.00
- Diluted shares
- 207M
Trading
- Previous close
- $0.08
- Open
- $0.08
- Day's range
- $0.08 – $0.08
- Volume
- 0
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | DQWS | S&P 500 | Difference | DQWS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | 0.0% | +0.6% | −0.6 pts | ||
| 3 months | +171.0% | +3.4% | +167.6 pts | ||
| Year to date | +115.4% | +13.3% | +102.1 pts | ||
| 1 year | +162.5% | +16.6% | +145.9 pts | ||
| 3 years | -16.8% | +86.4% | −103.2 pts | -6.0% | +23.1% |
| 5 years | -95.1% | +81.9% | −176.9 pts | -45.2% | +12.7% |
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
About DSwiss
Perfumes, Cosmetics & Other Toilet Preparations
DSwiss, Inc. is a biotech nutraceutical and turnkey private-label original design and original equipment manufacturer (ODM/OEM). Operating through its business segments of healthcare products and services alongside investment holding, the company develops, manufactures, and packages personal care, skincare, functional foods, and health supplements, including weight management beverages and immune enhancers. Its portfolio also features meal replacement nutrition, traditional plant-based medicines, and pet wellness supplements and grooming products. The company primarily serves corporate partners, brand owners, healthcare providers, and corporate wellness programs requiring custom formulations and private-label contract manufacturing services.
Company profile, executives and historyDSwiss stock: common questions
What is DSwiss's stock price?
DQWS closed at $0.08 on Oct 19, 2026, up 0.00% on the day.
What is DSwiss's market cap?
DSwiss was worth $17.38M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is DQWS's P/E ratio?
DSwiss lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.00), so it has no meaningful P/E ratio.
How much revenue does DSwiss make?
DSwiss reported revenue of $1.89M for the twelve months to Jun 30, 2026, down 53.8% from a year earlier.
Does DSwiss pay a dividend?
No. DSwiss has not paid a cash dividend over the last twelve months.
How has DQWS stock performed over the past year?
Including dividends, DQWS returned +162.5% over the past year, against +16.6% for the S&P 500.
Who are DSwiss's competitors?
Companies most similar to DSwiss by business, industry and size include SHFH, CSCIF, XAGE, BYAH, YCBD.
See a number that looks wrong?